Kidney transplantation from anti-HBc+ donors: Results from a retrospective Italian study

Transplantation

Volumn 81, Issue 1, 2006, Pages 76-80

  De Feo, Tullia M ^a   Grossi, Paolo ^b   Poli, Francesca ^a   Mozzi, Fulvio ^a   Messa, Piergiorgio ^a   Minetti, Enrico ^c   Sandrini, Silvio ^d   Boschiero, Luigi ^e   Rigotti, Paolo ^f   Maresca, Cristina ^g   Rolla, Davide ^h   Chiaramonte, Stefano ⁱ   Gotti, Eliana ^j   Caldara, Rossana ^k   Briano, Giulio ^l   Scalamogna, Mario ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c AO Niguarda Ca Granda   (Italy)

^d Divisione di Nefrologia e Dialisi   (Italy)

^e Centro Trapianti Renali   (Italy)

^f Ospedale Giustinianeo   (Italy)

^g Centro Trapianto di Rene   (Italy)

^h Divisione di Nefrologia   (Italy)

ⁱ AO S: Bortolo   (Italy)

^j OSPEDALI RIUNITI   (Italy)

^k SAN RAFFAELE HOSPITAL   (Italy)

^l AO Santa Corona   (Italy)

more..

Author keywords

Anti HBc+ donors; HBV transmission; Kidney transplantation; Transplantation

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADULT; ANTIBODY SCREENING; ARTICLE; CADAVER KIDNEY; CONTROLLED STUDY; CONVALESCENCE; DONOR; FEMALE; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; RECIPIENT; SEROPREVALENCE; SURVIVAL RATE; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INFANT; ITALY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; RETROSPECTIVE STUDIES; TISSUE DONORS;

EID: 31044452236     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000189930.89031.1b     Document Type: Article

References (19)

1. Wachs ME, Amend WJ, Ascher NL, et al. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation 1995; 59 (2): 230-234.
2. de Villa VH, Chen YS, Chen CL. Hepatitis B core antibody-positive grafts: recipient's risk. Transplantation 2003; 75(3 Suppl): S49-S53.
3. Douglas DD, Rakela J, Mamish D. Transmission of Hepatitis B Virus (HBV) infection from orthotopic donor livers. Hepatology 1992; 16: 49A.
4. Chazouillers O, Mamish D, Kim M, et al. "Occult" hepatitis B virus as a source of infection in liver transplant recipients. Lancet 1994; 343: 142.
5. Cirocco R, Zucker K, Contreras N, et al. The presence of hepatitis B core antibody does not preclude kidney donation: lack of viral DNA in the serum and biopsies of core antibody-positive donors and clinical follow-up. Transplantation 1997; 63 (11): 1702-1703.
6. Santos AF, Busetto F, Franco R, et al. Renal transplantation using hepatitis B or C serology-positive donors. Transplant Proc 1997; 29 (8): 3320.
7. Satterthwaite R, Ozgu I, Shidban H, et al. Risks of transplanting kidneys from hepatitis B surface antigen-negative, hepatitis B core antibody-positive donors. Transplantation 1997; 64 (3): 432-435.
8. Fong TL, Bunnapradist S, Jordan SC, Cho YW. Impact of hepatitis B core antibody status on outcomes of cadaveric renal transplantation: analysis of United network of organ sharing database between 1994 and 1999. Transplantation 2002; 73 (1): 85-89.
9. Stroffolini T, Mele A, Tosti ME, et al. The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy. J Hepatol 2000; 33: 980-985.
10. Sirchia G, Poli F, Cardillo M, et al. Cadaver kidney allocation in the north Italy transplant program on the eve of the new millennium. In Clinical Transplants. Cecka JM, Terasaki PI (eds). Los Angeles: UCLA Tissue Typing Laboratory, 1998: 133-145.
11. Harnett JD, Zeldis JB, Parfrey PS, et al. Hepatitis B disease in dialysis and transplant patients. Further epidemiologic and serologic studies. Transplantation 1987; 44 (3): 369-376.
12. Degos F, Lugassy C, Degott C, et al. Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients. A prospective study of 90 patients. Gastroenterology 1988; 94 (1): 151-156.
13. Madayag RM, Johnson LB, Bartlett ST, et al. Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease. Transplantation 1997; 64 (12): 1781-1786.
14. Natov SN, Pereira BJ. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 1: hepatitis B virus). Transpl Infect Dis 2002; 4 (3): 117-123.
15. Ganem D, Prince AM. Hepatitis B virus infection - Natural history and clinical consequences. N Engl J Med 2004; 350: 1118-1129.
16. Liang R, Lau GK, Kwong YL. Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: A review of the problem. J Clin Oncol 1999; 17 (1): 394-398.
17. Uemoto S, Sugiyama K, Marusawa H, et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation 1998; 65 (4): 494-499.
18. Lee KH, Wai CT, Lim SG, et al. Risk for de novo hepatitis B from antibody to hepatitis B core antigen-positive donors in liver transplantation in Singapore. Liver Transpl 2001; 7: 469-470.
19. Tosti ME, Solinas S, Prati D, et al. An estimate of the current risk of transmitting blood-borne infections through blood transfusion in Italy. Br J Haematol 2002; 117 (1): 215-219.